These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30482722)

  • 1. Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations.
    Ayuso JM; Gillette A; Lugo-Cintrón K; Acevedo-Acevedo S; Gomez I; Morgan M; Heaster T; Wisinski KB; Palecek SP; Skala MC; Beebe DJ
    EBioMedicine; 2018 Nov; 37():144-157. PubMed ID: 30482722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.
    Bischel LL; Beebe DJ; Sung KE
    BMC Cancer; 2015 Jan; 15():12. PubMed ID: 25605670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects.
    Sung KE; Yang N; Pehlke C; Keely PJ; Eliceiri KW; Friedl A; Beebe DJ
    Integr Biol (Camb); 2011 Apr; 3(4):439-50. PubMed ID: 21135965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma
    Kulwatno J; Gong X; DeVaux R; Herschkowitz JI; Mills KL
    Tissue Eng Part A; 2021 Apr; 27(7-8):454-466. PubMed ID: 33397202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.
    Dang TT; Prechtl AM; Pearson GW
    Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
    J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.
    Truong DD; Kratz A; Park JG; Barrientos ES; Saini H; Nguyen T; Pockaj B; Mouneimne G; LaBaer J; Nikkhah M
    Cancer Res; 2019 Jun; 79(12):3139-3151. PubMed ID: 30992322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation.
    Shah S; Brock EJ; Jackson RM; Ji K; Boerner JL; Sloane BF; Mattingly RR
    Neoplasia; 2018 Sep; 20(9):951-963. PubMed ID: 30144784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
    Damaghi M; West J; Robertson-Tessi M; Xu L; Ferrall-Fairbanks MC; Stewart PA; Persi E; Fridley BL; Altrock PM; Gatenby RA; Sims PA; Anderson ARA; Gillies RJ
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33452133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
    Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microengineered pathophysiological model of early-stage breast cancer.
    Choi Y; Hyun E; Seo J; Blundell C; Kim HC; Lee E; Lee SH; Moon A; Moon WK; Huh D
    Lab Chip; 2015 Aug; 15(16):3350-7. PubMed ID: 26158500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.
    Bertagnolo V; Grassilli S; Volinia S; Al-Qassab Y; Brugnoli F; Vezzali F; Lambertini E; Palomba M; Piubello Q; Orvieto E; Natali C; Piva R; Croce CM; Capitani S
    Mol Carcinog; 2019 May; 58(5):708-721. PubMed ID: 30582225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
    Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
    BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
    Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients.
    Ayuso JM; Virumbrales-Munoz M; McMinn PH; Rehman S; Gomez I; Karim MR; Trusttchel R; Wisinski KB; Beebe DJ; Skala MC
    Lab Chip; 2019 Oct; 19(20):3461-3471. PubMed ID: 31506657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
    Ory V; Kietzman WB; Boeckelman J; Kallakury BV; Wellstein A; Furth PA; Riegel AT
    Breast Cancer Res Treat; 2018 May; 169(1):47-57. PubMed ID: 29350308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.
    Krstic M; Kolendowski B; Cecchini MJ; Postenka CO; Hassan HM; Andrews J; MacMillan CD; Williams KC; Leong HS; Brackstone M; Torchia J; Chambers AF; Tuck AB
    J Pathol; 2019 Jun; 248(2):191-203. PubMed ID: 30697731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.